HHLR ADVISORS, LTD.
Institutional investor · Portfolio as of Q2 2019
Top Holdings43 positions
BEIGENE LTD | 4.4M | $550.1M | 12.3% | $140.26 | -11.63% | 3 qtrssince 2018-Q4 | Unchanged 0 |
JD.COM INC | 15.8M | $477.1M | 10.7% | $20.05 | +37.10% | 3 qtrssince 2018-Q4 | Increased 65 |
TAL EDUCATION GROUP | 11.4M | $434.7M | 9.7% | $29.99 | +27.06% | 3 qtrssince 2018-Q4 | Unchanged 0 |
IQIYI INC SPONSORED ADS | 14.5M | $299.6M | 6.7% | $22.81 | -9.48% | 3 qtrssince 2018-Q4 | Increased 70 |
CHINA BIOLOGIC PRODS HLDGS I | 2.8M | $262.2M | 5.9% | — | — | 3 qtrssince 2018-Q4 | Unchanged 0 |
ALIBABA GROUP HLDG LTD | 1.4M | $239.2M | 5.3% | $128.99 | +23.62% | 3 qtrssince 2018-Q4 | Unchanged 0 |
Meta Platforms Inc | 1.2M | $227.7M | 5.1% | $165.53 | +15.79% | 2 qtrssince 2019-Q1 | Unchanged 0 |
| 1.7M | $164.4M | 3.7% | — | — | 2 qtrssince 2019-Q1 | Increased 91 | |
PINDUODUO INC | 7.2M | $148.5M | 3.3% | $21.88 | -5.70% | 3 qtrssince 2018-Q4 | Increased 91 |
58 COM INC | 2.4M | $146.8M | 3.3% | — | — | 1 qtr | New 85 |
SEA LTD SPONSORD ADS | 4.3M | $142.8M | 3.2% | $23.52 | +41.24% | 2 qtrssince 2019-Q1 | Unchanged 0 |
BLUEPRINT MEDICINES CORP | 1.5M | $141.4M | 3.2% | — | — | 3 qtrssince 2018-Q4 | Unchanged 0 |
MONDELEZ INTL INC | 2.5M | $137.3M | 3.1% | $33.70 | +36.47% | 3 qtrssince 2018-Q4 | Decreased 0 |
BILIBILI INC SPONS ADS REP Z | 8.1M | $131.6M | 2.9% | $16.18 | +0.55% | 3 qtrssince 2018-Q4 | Increased 84 |
FIBROGEN INC | 2.7M | $123.1M | 2.8% | — | — | — | Increased 68 |
Tesla Inc | 520,580 | $116.3M | 2.6% | $14.90 | 0.00% | 1 qtr | New 79 |
MELCO RESORTS AND ENTMNT LTD | 4.4M | $95.5M | 2.1% | $21.86 | -3.02% | 3 qtrssince 2018-Q4 | Unchanged 0 |
ENSTAR GROUP LIMITED | 543,487 | $94.7M | 2.1% | — | — | 2 qtrssince 2019-Q1 | Unchanged 0 |
APELLIS PHARMACEUTICALS INC | 2.6M | $65.4M | 1.5% | $14.10 | +79.74% | 3 qtrssince 2018-Q4 | Unchanged 0 |
SNAP INC | 4.5M | $63.9M | 1.4% | $14.30 | 0.00% | 1 qtr | New 68 |
HHLR ADVISORS, LTD. manages $4.5B across 43 positions as of Q2 2019. Top holdings: ONC (12.3%), JD (10.7%), TAL (9.7%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 2.5/5.0.
Active quarter - 13 new positions, 0 exits, 6 increased. Top move: PDD (INCREASED, conviction 91). Portfolio: $4.5B across 43 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR